Connect Biopharma Holdings Ltd (CNTB) Institutional Shareholders
Connect Biopharma Holdings Ltd (CNTB) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $33.02M in CNTB holdings during the latest filing period.
Ikarian Capital, Llc is currently the largest disclosed institutional shareholder of CNTB tracked by InsiderSet, reporting ownership valued at approximately $10.80M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $5.81M, representing an estimated loss of -46.22% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 81% of the total disclosed CNTB value among the investors covered in this analysis. Major shareholders include Ikarian Capital, Llc, 683 Capital Management, Llc, Boothbay Fund Management, Llc, and several other long-term asset managers with concentrated positions in Connect Biopharma Holdings Ltd (CNTB).
This page ranks the largest institutional CNTB shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
55
Total Reported Value
$33.02M
Largest Holder
Ikarian Capital, Llc
Largest Position
$10.80M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
66
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, Llc | 1.77% | 4,538,534 | $10,801,710 | $5,809,324 | -$4,992,386 | -46.22% | |
| 683 Capital Management, Llc | 0.28% | 1,285,000 | $3,058,300 | $1,644,800 | -$1,413,500 | -46.22% | |
| Boothbay Fund Management, Llc | 0.04% | 973,732 | $2,317,482 | $1,246,377 | -$1,071,105 | -46.22% | |
| Blackrock, Inc. | 0.00% | 871,653 | $2,074,534 | $1,115,716 | -$958,818 | -46.22% | |
| Perceptive Advisors Llc | 0.03% | 792,696 | $1,886,616 | $1,014,651 | -$871,965 | -46.22% | |
| Adar1 Capital Management, Llc | 0.08% | 700,000 | $1,666,000 | $896,000 | -$770,000 | -46.22% | |
| Bml Capital Management, Llc | 0.78% | 573,287 | $1,364,423 | $733,807 | -$630,616 | -46.22% | |
| Silverarc Capital Management, Llc | 0.14% | 545,000 | $1,297,100 | $697,600 | -$599,500 | -46.22% | |
| Richmond Brothers, Inc. | 0.66% | 535,612 | $1,274,755 | $685,583 | -$589,172 | -46.22% | |
| Knott David M Jr | 0.56% | 444,862 | $1,058,772 | $569,423 | -$489,349 | -46.22% | |
| Stonepine Capital Management, Llc | 0.66% | 364,254 | $866,925 | $466,245 | -$400,680 | -46.22% | |
| Marshall Wace, Llp | 0.00% | 335,642 | $798,830 | $429,622 | -$369,208 | -46.22% | |
| Geode Capital Management, Llc | 0.00% | 257,454 | $612,740 | $329,541 | -$283,199 | -46.22% | |
| Two Sigma Investments, Lp | 0.00% | 199,381 | $474,527 | $255,208 | -$219,319 | -46.22% | |
| Diadema Partners Lp | 0.17% | 196,985 | $468,824 | $252,141 | -$216,683 | -46.22% | |
| Burkehill Global Management, Lp | 0.01% | 150,000 | $357,000 | $192,000 | -$165,000 | -46.22% | |
| Vanguard Portfolio Management Llc | 0.00% | 102,755 | $244,557 | $131,526 | -$113,031 | -46.22% | |
| Susquehanna International Group, Llp | 0.00% | 102,148 | $243,112 | $130,749 | -$112,363 | -46.22% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 87,300 | $207,774 | $111,744 | -$96,030 | -46.22% |
| Northern Trust Corp | 0.00% | 82,862 | $197,212 | $106,063 | -$91,149 | -46.22% | |
| Simplex Trading, Llc | 0.01% | 81,948 | $195,036 | $104,893 | -$90,143 | -46.22% | |
| State Street Corp | 0.00% | 66,700 | $158,746 | $85,376 | -$73,370 | -46.22% | |
| Ubs Group Ag | 0.00% | 66,451 | $158,153 | $85,057 | -$73,096 | -46.22% | |
| Persistent Asset Partners Ltd | 0.04% | 49,873 | $118,698 | $63,837 | -$54,861 | -46.22% | |
| Koa Wealth Management, Llc | 0.08% | 49,600 | $118,048 | $63,488 | -$54,560 | -46.22% | |
| New York State Common Retirement Fund | 0.00% | 48,400 | $115,192 | $61,952 | -$53,240 | -46.22% | |
| Millennium Management Llc | 0.00% | 43,708 | $104,025 | $55,946 | -$48,079 | -46.22% | |
| Bank Of America Corp | 0.00% | 40,920 | $97,390 | $52,378 | -$45,012 | -46.22% | |
| Royal Bank Of Canada | 0.00% | 40,940 | $97,000 | $52,403 | -$44,597 | -45.98% | |
| Charles Schwab Investment Management Inc | 0.00% | 36,760 | $87,489 | $47,053 | -$40,436 | -46.22% | |
| Xtx Topco Ltd | 0.00% | 28,659 | $68,208 | $36,684 | -$31,524 | -46.22% | |
| Bank Of New York Mellon Corp | 0.00% | 23,953 | $57,008 | $30,660 | -$26,348 | -46.22% | |
| Nuveen, Llc | 0.00% | 19,773 | $47,060 | $25,309 | -$21,751 | -46.22% | |
| Y-Intercept (Hong Kong) Ltd | 0.00% | 15,069 | $35,864 | $19,288 | -$16,576 | -46.22% | |
| Wells Fargo & Company/Mn | 0.00% | 13,240 | $31,511 | $16,947 | -$14,564 | -46.22% | |
| Smartharvest Portfolios, Llc | 0.01% | 12,897 | $30,695 | $16,508 | -$14,187 | -46.22% | |
| Price T Rowe Associates Inc | 0.00% | 12,469 | $30,000 | $15,960 | -$14,040 | -46.80% | |
| Jpmorgan Chase & Co | 0.00% | 11,718 | $27,889 | $14,999 | -$12,890 | -46.22% | |
| Vanguard Fiduciary Trust Co | 0.00% | 11,314 | $26,927 | $14,482 | -$12,445 | -46.22% | |
| Monograph Wealth Advisors, Llc | 0.00% | 11,130 | $26,489 | $14,246 | -$12,243 | -46.22% | |
| Rhumbline Advisers | 0.00% | 10,979 | $26,124 | $14,053 | -$12,071 | -46.21% | |
| Morgan Stanley | 0.00% | 8,639 | $20,561 | $11,058 | -$9,503 | -46.22% | |
| Citigroup Inc | 0.00% | 6,986 | $16,627 | $8,942 | -$7,685 | -46.22% | |
| Mirae Asset Global Etfs Holdings Ltd. | 0.00% | 6,904 | $16,432 | $8,837 | -$7,595 | -46.22% | |
| Fny Investment Advisers, Llc | 0.00% | 5,000 | $11,000 | $6,400 | -$4,600 | -41.82% | |
| Barclays Plc | 0.00% | 2,879 | $6,852 | $3,685 | -$3,167 | -46.22% | |
| Legal & General Group Plc | 0.00% | 2,415 | $5,748 | $3,091 | -$2,657 | -46.22% | |
| Bnp Paribas Financial Markets | 0.00% | 2,290 | $5,450 | $2,931 | -$2,519 | -46.22% | |
| Russell Investments Group, Ltd. | 0.00% | 1,195 | $2,844 | $1,530 | -$1,314 | -46.22% | |
| Huntington National Bank | 0.00% | 996 | $2,370 | $1,275 | -$1,095 | -46.21% |
Frequently asked questions about CNTB
Who owns the most CNTB stock?
The largest holders of CNTB are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for Connect Biopharma Holdings Ltd (CNTB).
Is CNTB widely held by superinvestors?
Many widely followed stocks like CNTB appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CNTB is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.